Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAMPOLINE: Amiloride for Vascular Stiffness in ADPKD
NCT05228574Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Mar 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amiloride in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Erasmus MC. Started Mar 2022; status: completed.
02
Drugs
amiloride
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT05228574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05228574.